Resveratrol in cardioprotection: A therapeutic promise of alternative medicine

被引:199
作者
Das, DK [1 ]
Maulik, N [1 ]
机构
[1] Univ Connecticut, Sch Med, Cardiovasc Res Ctr, Dept Surg, Farmington, CT 06030 USA
关键词
D O I
10.1124/mi.6.1.7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resveratrol, a polyphenol phytoalexin, possesses diverse biochemical and physiological actions, including estrogenic, antiplatelet, and anti-inflammatory properties. Several recent studies determined the cardioprotective abilities of resveratrol. Both in experiments (acute) and in chronic models, resveratrol attenuates myocardial ischemic reperfusion injury, atherosclerosis, and reduces ventricular arrhythmias. It appears that resveratrol-mediated cardioprotection is achieved through the preconditioning effect (the best yet devised method of cardioprotection), rather than direct protection. Thus, resveratrol likely fulfills the definition of a pharmacological preconditioning compound and gives hope to the therapeutic promise of alternative medicine.
引用
收藏
页码:36 / 47
页数:12
相关论文
共 142 条
  • [1] Role of mitogen-activated protein kinases in ischemia and reperfusion injury - The good and the bad
    Abe, J
    Baines, CP
    Berk, BC
    [J]. CIRCULATION RESEARCH, 2000, 86 (06) : 607 - 609
  • [2] c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1 (BMK1)
    Abe, J
    Takahashi, M
    Ishida, M
    Lee, JD
    Berk, BC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) : 20389 - 20394
  • [3] Nitric oxide controls Src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism
    Akhand, AK
    Pu, MY
    Senga, T
    Kato, M
    Suzuki, H
    Miyata, T
    Hamaguchi, M
    Nakashima, I
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) : 25821 - 25826
  • [4] Ashby J, 1999, J APPL TOXICOL, V19, P39, DOI 10.1002/(SICI)1099-1263(199901/02)19:1&lt
  • [5] 39::AID-JAT534&gt
  • [6] 3.0.CO
  • [7] 2-M
  • [8] Bagchi D, 2001, DRUG EXP CLIN RES, V27, P233
  • [9] Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart
    Baines, CP
    Wang, L
    Cohen, MV
    Downey, JM
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (02) : 383 - 392
  • [10] Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton
    Baines, CP
    Liu, GS
    Birincioglu, M
    Critz, SD
    Cohen, MV
    Downey, JM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (04): : H1361 - H1368